{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T13:15:04Z","timestamp":1791983704930,"version":"4.4.0"},"reference-count":30,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To determine whether metabolic risk factors (MRFs), metabolic dysfunction\u2013associated steatotic liver disease (MASLD) and metabolic dysfunction\u2013associated steatohepatitis (MASH) are associated with incident mild cognitive impairment (MCI), vascular dementia (VD), and Alzheimer disease (AD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Retrospective cohort study using TriNetX (2003\u20132023) with Propensity score matching.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Multicenter, population-based sample from 69 U.S. healthcare organizations in the TriNetX electronic health record.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>Adults aged \u226550 years with \u22651 outpatient visit and sufficient clinical\/laboratory data. Individuals with prior diagnoses of cognitive impairment, cerebrovascular disease, advanced liver disease, malignancy, schizophrenia, or substance use disorders were excluded. Two matched cohorts were constructed: one with 3,546,833 individuals with MRFs and 3,546,833 healthy controls, and another with 525,844 individuals with MASLD\/MASH and 525,844 with MRFs only. Matching was based on age, sex, race, and ethnicity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec005\">\n                    <jats:title>Primary and secondary outcome measures<\/jats:title>\n                    <jats:p>Incident MCI, VD, and AD, identified using ICD-10 codes, assessed at 5\u201320-year intervals. Odds ratios (ORs) with 95% confidence intervals (CIs) were calculated using logistic regression. Outcomes were prespecified.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec006\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 7,818,146 participants (mean [SD] age, 64.9 [8.8] years; 52.0% female), individuals with MRFs had higher odds of VD (OR, 1.65; 95% CI, 1.63\u20131.67), MCI (OR, 1.45; 95% CI, 1.42\u20131.48), and AD (OR, 1.21; 95% CI, 1.19\u20131.24) vs healthy controls. Compared to the MRF group, individuals with MASLD\/MASH had lower odds of VD (OR, 0.86; 95% CI, 0.83\u20130.89) and AD (OR, 0.83; 95% CI, 0.78\u20130.88), but higher odds of MCI (OR, 1.37; 95% CI, 1.30\u20131.44); all\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u2009.001.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec007\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In this large, propensity-matched retrospective cohort study, MRFs were independently associated with significantly increased long-term odds of MCI, VD, and AD. MASLD\/MASH demonstrated a divergent cognitive risk profile relative to MRFs alone\u2014characterized by higher odds of MCI but paradoxically lower odds of VD and AD, a pattern that warrants cautious interpretation given potential competing mortality risk, survivor bias, and residual confounding. These findings suggest that MASLD\/MASH is associated with a distinct cognitive trajectory, highlighting the importance of early cognitive surveillance in this population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0353160","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T17:29:13Z","timestamp":1783618153000},"page":"e0353160","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Metabolic risk and metabolic dysfunction\u2013associated steatotic liver disease and steatohepatitis in cognitive decline: A retrospective cohort study"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1588-303X","authenticated-orcid":true,"given":"Ahmad Basil","family":"Nasir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yassine","family":"Kilani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Aldiabat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Abdelghany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4205-3074","authenticated-orcid":true,"given":"Youssef","family":"Hafez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitin","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud Y.","family":"Madi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis G.","family":"Wade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamran","family":"Qureshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lewis J.","family":"Frey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam D.","family":"Farmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7966-0500","authenticated-orcid":true,"given":"Wing-Kin","family":"Syn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,7,9]]},"reference":[{"issue":"3","key":"pone.0353160.ref001","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3502","article-title":"Metabolic syndrome and cardiovascular diseases: Going beyond traditional risk factors","volume":"38","author":"JL Silveira Rossi","year":"2022","journal-title":"Diabetes Metab Res Rev"},{"issue":"4","key":"pone.0353160.ref002","doi-asserted-by":"crossref","first-page":"101501","DOI":"10.1016\/j.aohep.2024.101501","article-title":"The Janus of a disease: Diabetes and metabolic dysfunction-associated fatty liver disease","volume":"29","author":"F Barrera","year":"2024","journal-title":"Ann Hepatol"},{"key":"pone.0353160.ref003","doi-asserted-by":"crossref","first-page":"1433857","DOI":"10.3389\/fcell.2024.1433857","article-title":"Systemic impacts of metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) on heart, muscle, and kidney related diseases","volume":"12","author":"R Sandireddy","year":"2024","journal-title":"Front Cell Dev Biol"},{"issue":"4","key":"pone.0353160.ref004","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1136\/gutjnl-2023-330595","article-title":"MASLD: a systemic metabolic disorder with cardiovascular and malignant complications","volume":"73","author":"G Targher","year":"2024","journal-title":"Gut"},{"key":"pone.0353160.ref005","doi-asserted-by":"crossref","DOI":"10.12659\/MSM.943417","article-title":"From Liver to Brain: How MAFLD\/MASLD Impacts Cognitive Function","volume":"30","author":"D Medina-Julio","year":"2024","journal-title":"Med Sci Monit"},{"issue":"10","key":"pone.0353160.ref006","article-title":"The burden of nonalcoholic fatty liver disease (NAFLD) is rapidly growing in every region of the world from 1990 to 2019","volume":"7","author":"JM Paik","year":"2023","journal-title":"Hepatol Commun"},{"issue":"8","key":"pone.0353160.ref007","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.tem.2024.02.007","article-title":"Current status and future trends of the global burden of MASLD","volume":"35","author":"L Miao","year":"2024","journal-title":"Trends Endocrinol Metab"},{"issue":"4","key":"pone.0353160.ref008","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"ZM Younossi","year":"2023","journal-title":"Hepatology"},{"issue":"3","key":"pone.0353160.ref009","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1159\/000541696","article-title":"The Link between Metabolic Syndrome and the Brain","volume":"106","author":"S Zouridis","year":"2025","journal-title":"Digestion"},{"issue":"14","key":"pone.0353160.ref010","doi-asserted-by":"crossref","first-page":"7621","DOI":"10.3390\/ijms25147621","article-title":"Metabolic Crosstalk between Liver and Brain: From Diseases to Mechanisms","volume":"25","author":"X Yang","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"12","key":"pone.0353160.ref011","doi-asserted-by":"crossref","first-page":"101185","DOI":"10.1016\/j.jhepr.2024.101185","article-title":"Lipid metabolism in MASLD and MASH: From mechanism to the clinic","volume":"6","author":"F Carli","year":"2024","journal-title":"JHEP Rep"},{"issue":"2","key":"pone.0353160.ref012","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/ddr.21643","article-title":"Insulin resistance and impaired lipid metabolism as a potential link between diabetes and Alzheimer\u2019s disease","volume":"81","author":"JA Kulas","year":"2020","journal-title":"Drug Dev Res"},{"key":"pone.0353160.ref013","doi-asserted-by":"crossref","first-page":"653651","DOI":"10.3389\/fnins.2021.653651","article-title":"Inflammation and Insulin Resistance as Risk Factors and Potential Therapeutic Targets for Alzheimer\u2019s Disease","volume":"15","author":"A Vinuesa","year":"2021","journal-title":"Front Neurosci"},{"issue":"1","key":"pone.0353160.ref014","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s13195-024-01498-5","article-title":"Association of MAFLD and MASLD with all-cause and cause-specific dementia: a prospective cohort study","volume":"16","author":"X Bao","year":"2024","journal-title":"Alzheimers Res Ther"},{"issue":"6","key":"pone.0353160.ref015","first-page":"1034","article-title":"Association between Metabolic Dysfunction-associated Fatty Liver Disease and Cognitive Impairment","volume":"10","author":"Q Yu","year":"2022","journal-title":"J Clin Transl Hepatol"},{"key":"pone.0353160.ref016","doi-asserted-by":"crossref","first-page":"1451908","DOI":"10.3389\/fendo.2024.1451908","article-title":"Metabolic-associated steatotic liver disease and risk of Alzheimer\u2019s disease: a real-world retrospective cohort study","volume":"15","author":"J Zhang","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"pone.0353160.ref017","doi-asserted-by":"crossref","first-page":"738835","DOI":"10.3389\/fmed.2021.738835","article-title":"Non-alcoholic Fatty Liver Disease and Longitudinal Cognitive Changes in Middle-Aged and Elderly Adults","volume":"8","author":"Q Liu","year":"2022","journal-title":"Front Med (Lausanne)"},{"issue":"6","key":"pone.0353160.ref018","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000200770","article-title":"Association of Nonalcoholic Fatty Liver Disease and Fibrosis With Incident Dementia and Cognition: The Rotterdam Study","volume":"99","author":"T Xiao","year":"2022","journal-title":"Neurology"},{"issue":"9","key":"pone.0353160.ref019","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0223019","article-title":"Neurobehavioral dysfunction in non-alcoholic steatohepatitis is associated with hyperammonemia, gut dysbiosis, and metabolic and functional brain regional deficits","volume":"14","author":"SG Higarza","year":"2019","journal-title":"PLoS One"},{"issue":"22","key":"pone.0353160.ref020","doi-asserted-by":"crossref","first-page":"14254","DOI":"10.3390\/ijms232214254","article-title":"Liver Steatosis and Steatohepatitis Alter Bile Acid Receptors in Brain and Induce Neuroinflammation: A Contribution of Circulating Bile Acids and Blood-Brain Barrier","volume":"23","author":"N Fiaschini","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"1","key":"pone.0353160.ref021","doi-asserted-by":"crossref","first-page":"10616","DOI":"10.1038\/s41598-025-94234-4","article-title":"Early stage of metabolic dysfunction associated steatotic liver disease disrupts circadian rhythm and induces neuroinflammation in rats","volume":"15","author":"P-H Graindorge","year":"2025","journal-title":"Sci Rep"},{"issue":"1","key":"pone.0353160.ref022","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/s12974-020-01876-4","article-title":"Lipocalin 2 induces neuroinflammation and blood-brain barrier dysfunction through liver-brain axis in murine model of nonalcoholic steatohepatitis","volume":"17","author":"A Mondal","year":"2020","journal-title":"J Neuroinflammation"},{"issue":"18","key":"pone.0353160.ref023","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.3390\/cells12182331","article-title":"Cognitive Functions, Neurotransmitter Alterations, and Hippocampal Microstructural Changes in Mice Caused by Feeding on Western Diet","volume":"12","author":"RJP Custodio","year":"2023","journal-title":"Cells"},{"issue":"6","key":"pone.0353160.ref024","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.jagp.2019.01.214","article-title":"Metabolic Syndrome, Mild Cognitive Impairment, and Dementia: A Meta-Analysis of Longitudinal Studies","volume":"27","author":"AR Atti","year":"2019","journal-title":"Am J Geriatr Psychiatry"},{"issue":"9","key":"pone.0353160.ref025","article-title":"Impact of Worsened Metabolic Syndrome on the Risk of Dementia: A Nationwide Cohort Study","volume":"6","author":"Y-C Fan","year":"2017","journal-title":"J Am Heart Assoc"},{"issue":"8","key":"pone.0353160.ref026","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.2337\/dc24-0537","article-title":"Association of Metabolic Syndrome With Neuroimaging and Cognitive Outcomes in the UK Biobank","volume":"47","author":"D Qureshi","year":"2024","journal-title":"Diabetes Care"},{"issue":"2","key":"pone.0353160.ref027","doi-asserted-by":"crossref","first-page":"424","DOI":"10.3803\/EnM.2020.935","article-title":"Cumulative Exposure to Metabolic Syndrome Components and the Risk of Dementia: A Nationwide Population-Based Study","volume":"36","author":"Y Cho","year":"2021","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"2","key":"pone.0353160.ref028","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1601-5215.2011.00527.x","article-title":"Association between metabolic syndrome and cognitive decline: a systematic review of prospective population-based studies","volume":"23","author":"Z Hao","year":"2011","journal-title":"Acta Neuropsychiatr"},{"issue":"5","key":"pone.0353160.ref029","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1212\/01.wnl.0000234037.91185.99","article-title":"Association of metabolic syndrome with Alzheimer disease: a population-based study","volume":"67","author":"M Vanhanen","year":"2006","journal-title":"Neurology"},{"key":"pone.0353160.ref030","doi-asserted-by":"crossref","first-page":"981379","DOI":"10.3389\/fpsyg.2022.981379","article-title":"Metabolic syndrome and cognition: A systematic review across cognitive domains and a bibliometric analysis","volume":"13","author":"M Koutsonida","year":"2022","journal-title":"Front Psychol"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0353160","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T17:29:17Z","timestamp":1783618157000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0353160"}},"subtitle":[],"editor":[{"given":"Anna","family":"Di Sessa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,7,9]]},"references-count":30,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0353160","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,9]]}}}